Circulating α-klotho levels in CKD and relationship to progression

American Journal of Kidney Diseases

Volumn 61, Issue 6, 2013, Pages 899-909

  Kim, Hyoung Rae ^a   Nam, Bo Young ^a   Kim, Dong Wook ^b   Kang, Min Woong ^b   Han, Jae Hyun ^a   Lee, Mi Jung ^a   Shin, Dong Ho ^a   Doh, Fa Mee ^a   Koo, Hyang Mo ^a   Ko, Kwang Il ^a   Kim, Chan Ho ^a   Oh, Hyung Jung ^a   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a   Han, Dae Suk ^a   Han, Seung Hyeok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Klotho; chronic kidney disease; fibroblast growth factor 23 (FGF 23); kidney disease outcome

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; CREATININE; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POST HOC ANALYSIS; PROSPECTIVE STUDY; PROTEINURIA; RENAL REPLACEMENT THERAPY;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; GLUCURONIDASE; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 84877922921     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.01.024     Document Type: Article

References (41)

1. C. Baigent, K. Burbury, D. Wheeler Premature cardiovascular disease in chronic renal failure Lancet 356 9224 2000 147 152
2. C. Zoccali Cardiovascular risk in uraemic patients - is it fully explained by classical risk factors? Nephrol Dial Transplant 15 4 2000 454 457
3. P. Stenvinkel, J.J. Carrero, J. Axelsson Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3 2 2008 505 521
4. R.G. Fassett, S.K. Venuthurupalli, G.C. Gobe Biomarkers in chronic kidney disease: a review Kidney Int 80 8 2011 806 821
5. M. Kuro-o, Y. Matsumura, H. Aizawa Mutation of the mouse klotho gene leads to a syndrome resembling ageing Nature 390 6655 1997 45 51
6. H. Kurosu, Y. Ogawa, M. Miyoshi Regulation of fibroblast growth factor-23 signaling by klotho J Biol Chem 281 10 2006 6120 6123
7. M. Kuro-o Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism Curr Opin Nephrol Hypertens 15 4 2006 437 441
8. H. Kurosu, M. Yamamoto, J.D. Clark Suppression of aging in mice by the hormone Klotho Science 309 5742 2005 1829 1833
9. M. Kuro-o Klotho as a regulator of oxidative stress and senescence Biol Chem 389 3 2008 233 241
10. Y. Zhao, S. Banerjee, N. Dey Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation Diabetes 60 7 2011 1907 1916
11. R. Nagai, Y. Saito, Y. Ohyama Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases Cell Mol Life Sci 57 5 2000 738 746
12. M.C. Hu, M. Shi, J. Zhang Klotho deficiency causes vascular calcification in chronic kidney disease J Am Soc Nephrol 22 1 2011 124 136
13. H. Mitani, N. Ishizaka, T. Aizawa In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage Hypertension 39 4 2002 838 843
14. H. Sugiura, T. Yoshida, K. Tsuchiya Klotho reduces apoptosis in experimental ischaemic acute renal failure Nephrol Dial Transplant 20 12 2005 2636 2645
15. Y. Haruna, N. Kashihara, M. Satoh Amelioration of progressive renal injury by genetic manipulation of klotho gene Proc Natl Acad Sci U S A 104 7 2007 2331 2336
16. N. Koh, T. Fujimori, S. Nishiguchi Severely reduced production of klotho in human chronic renal failure kidney Biochem Biophys Res Commun 280 4 2001 1015 1020
17. M.C. Hu, M.J. Shi, J.N. Zhang Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective Kidney Int 78 12 2010 1240 1251
18. Y. Shimamura, K. Hamada, K. Inoue Serum levels of soluble secreted alpha-klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis Clin Exp Nephrol 16 5 2012 722 729
19. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 2002 S1 S266 (suppl 1)
20. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
21. Y. Yamazaki, A. Imura, I. Urakawa Establishment of sandwich ELISA for soluble alpha-klotho measurement: age-dependent change of soluble alpha-klotho levels in healthy subjects Biochem Biophys Res Commun 398 3 2010 513 518
22. P. Kennedy A Guide to Econometrics 1992 MIT Press Cambridge, MA
23. M. Charlson, T.P. Szatrowski, J. Peterson, J. Gold Validation of a combined comorbidity index J Clin Epidemiol 47 11 1994 1245 1251
24. O. Asai, K. Nakatani, T. Tanaka Decreased renal alpha-klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion Kidney Int 81 6 2012 539 547
25. C.Y. Sun, S.C. Chang, M.S. Wu Suppression of klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation Kidney Int 81 7 2012 640 650
26. S. Devaraj, B. Syed, A. Chien, I. Jialal Validation of an immunoassay for soluble klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease Am J Clin Pathol 137 3 2012 479 485
27. H. Sugiura, K. Tsuchiya, K. Nitta Circulating levels of soluble alpha-klotho in patients with chronic kidney disease Clin Exp Nephrol 15 5 2011 795 796
28. D. Prie, G. Friedlander Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/klotho system Clin J Am Soc Nephrol 5 9 2010 1717 1722
29. 3 production J Biol Chem 278 4 2003 2206 2211
30. T. Shigematsu, J.J. Kazama, T. Yamashita Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency Am J Kidney Dis 44 2 2004 250 256
31. O. Gutierrez, T. Isakova, E. Rhee Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease J Am Soc Nephrol 16 7 2005 2205 2215
32. T. Isakova, P. Wahl, G.S. Vargas Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease Kidney Int 79 12 2011 1370 1378
33. D. Fliser, B. Kollerits, U. Neyer Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study J Am Soc Nephrol 18 9 2007 2600 2608
34. S.M. Titan, R. Zatz, F.G. Graciolli FGF-23 as a predictor of renal outcome in diabetic nephropathy Clin J Am Soc Nephrol 6 2 2011 241 247
35. J. Kendrick, A.K. Cheung, J.S. Kaufman FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis J Am Soc Nephrol 22 10 2011 1913 1922
36. S.L. Ferrari, J.P. Bonjour, R. Rizzoli Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men J Clin Endocrinol Metab 90 3 2005 1519 1524
37. W.J. Fassbender, V. Brandenburg, S. Schmitz Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients Clin Lab 55 3-4 2009 144 152
38. O.M. Gutierrez, M. Mannstadt, T. Isakova Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 6 2008 584 592
39. Y. Wang, Z. Sun Current understanding of klotho Ageing Res Rev 8 1 2009 43 51
40. R. Canalejo, A. Canalejo, J.M. Martinez-Moreno FGF23 fails to inhibit uremic parathyroid glands J Am Soc Nephrol 21 7 2010 1125 1135
41. I. Pavik, P. Jaeger, L. Ebner Soluble klotho and autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 7 2 2012 248 257